Zhicong Chen

Zhicong Chen

Auto-generated profile, based on publicly available information

Zhicong Chen

Fengxian Hospital, Southern Medical University, Shanghai, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2024 in Clinical Psychopharmacology and Neuroscience
Verified
Journal Article
Open access
PDF file
ZSZuanjun Su
Zuanjun Su
ZCZhicong Chen
Zhicong Chen
JCJinming Cao
Jinming Cao
CLCanye Li
Canye Li
JDJingjing Duan
Jingjing Duan
FXFeng Xu
Feng Xu
Zuanjun Su, Zhicong Chen, Jinming Cao, Canye Li, Jingjing Duan, Ting Zhou, Zhen Yang, Yuanchi Cheng, Zhijun Xiao, Feng Xu. Clin Psychopharmacol Neurosci 2024;22:594-609. https://doi.org/10.9758/cpn.24.1167


15 October 2024 in Research Square
Verified
Preprint
Open access
PDF file
FXFeng Xu
Feng Xu
ZCZhicong Chen
Zhicong Chen
JCJinming Cao
Jinming Cao
ZXZhijun Xiao
Zhijun Xiao
ZYZhen Yang
Zhen Yang
TZTing Zhou
Ting Zhou
Depression is prevalent in ovarian cancer patients and contribute to the progression of the disease. However, the underlying mechanism remains unclear. In vivo, we established a comorbidity mouse model of ovarian cancer and depression. We found that chronic stress induced depression-like behaviors and promoted inoculated ovarian tumor growth in mice. Histidine decarboxylase (HDC) level was downregulated both in tumor tissue and in plasma of model mice. Exogenous histamine (HIS) treatment significantly alleviated chronic stress-induced depression-like behaviors and inhibited ovarian tumor growth, as well as decreased serum levels of inflammatory factors IL-6 and IL-17A, stress hormones norepinephrine (NE) and cortisol (COR), and 5-hydroxytryptamine (5-HT). Furthermore, HIS treatment regulated the immune response, particularly by increasing the percentage of CD3+ T cells, CD8+ cytotoxic T (Tc) cells, and decreasing the secretion of IL-17A. In vitro research of A2780 and ES-2 cell lines, NE and COR treatment down-regulated HDC expression and promoted cancer cells proliferation, migration, and invasion. HIS treatment reversed these effects. Preliminary mechanism research showed that chronic stress downregulated HDC expression and promoted ovarian cancer progression via IL-6/STAT3/S100A9 pathway. HIS may be a potential molecule for treating comorbidity of ovarian cancer and depression.